Wiley Bros. Aintree Capital, LLC Boston Scientific Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 9,812 shares of BSX stock, worth $852,466. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,812
Previous 5,016
95.61%
Holding current value
$852,466
Previous $343,000
120.12%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,484Shares Held
1.21BCall Options Held
8.09MPut Options Held
8.42M-
Vanguard Group Inc Valley Forge, PA130MShares$11.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.34 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.3 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.79 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $124B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...